The effect of tert-butyl hydroperoxide on peritoneal macrophages and the protective effect of protein-bound polysaccharide administered intraperitoneally and orally

American Journal of Chinese Medicine

Volumn 26, Issue 3-4, 1998, Pages 301-310

  Zhou, Mei ^a,b   Chen, Yuan ^a   Ouyang, Qian ^a   Liu, Shangxi ^a   Pang, Zhan Jun ^a   Wan, Jennifer ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; KRESTIN; PROTEOGLYCAN; PS-K; TERT BUTYL HYDROPEROXIDE;

ANIMAL; ARTICLE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; ORAL DRUG ADMINISTRATION; PERITONEUM MACROPHAGE;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CELL SURVIVAL; DRUG INTERACTIONS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES, PERITONEAL; MALE; MICE; PROTEOGLYCANS; TERT-BUTYLHYDROPEROXIDE;

EID: 0032240278     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/s0192415x98000348     Document Type: Article

References (39)

1. Bagchi D., E.A. Hassoun, M. Bagchi and S.J. Stohs. Protective effects of free radical scavengers and antioxidants against smokeless tobacco extract (STE) induced oxidative stress in macrophage J774A1 cell cultures. Arch Environ Contain Toxicol, 29(3): 424-428, 1995.
2. Bolton E.J., VV. Jessup and K.K. Stanley. Enhanced LDL oxidation by murine macrophage foam cells and their failure to secret nitric oxide. Atherosclerosis, 106: 213-223, 1994.
3. Chen Y., M. Zhou, J. Li and Z. Quo. Injurious effect of reactive oxygen species on macrophage and its prevention by PSK. J Clin Lab Imnnmol, 43: 99-115, 1994.
4. Chen Y, M. Zhou, S.X. Liu and Y. Le. PSK protects macrophages from lipoperoxide accumulation and foam cell formation caused by oxidatively modified low density lipoprotein. Atherosclerosis, 124: 171-181,1996.
5. Chen Y, M. Zhou, N. Lou, S.X. Liu, Z.J. Pang and J. Wan. The polysaccharide Krestin prevents plaque formation of experimentally atherosclerotic rabbits. Med Sci Res. 25: 297-301, 1997.
6. Fujii T., K. Suito, K. Matsunaga, Y. Oguchi, M. Ikuzawa, T. Furusho and T. Taguchi. Prolongation of the survival period with the biological response modifier PSK in rats bearing Nmethyl-Nnitrosourea-induced mammary gland tumors. In Vivo, 9(1): 55-57, 1995.
7. Guidarelli A., L. Brambilla, C. Rota, A. Tomasi, F. Cattabeni and O. Cantoni. The respiratory chain poison antimycin A promotes the formation of DNA single-strand breaks and reduces toxicity in U937 cell exposed to t-butyl hydroperoxide. Biochem J, 317(pt 2): 371-375, 1996.
8. Hirai R., Y. Oguchi, N. Sugita, K. Matsunaga and K. Nomoto. Enhancement of T-cell proliferation by PSK. hit J Immimopharmacol. 15(16): 745-750, 1993.
9. Kato M., K. Hirose, M. Hakozaki, M. Ohno, Y. Saito, R. Izutani, Y. Noguchi Hori, S. Okumoto and D. Kuroda. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein bound polysaccharide. Cancer Immunol Iinmunother, 40(3): 152-156, 1995.
10. Kobayashi Y., K. Kariya, K. Suigenji and K. Nakamura. Enhancement cisdiaminedichloroplastinum by the activity of protein-bound polysaccharide of Coriolus versicolor QUEL (PSK) in vitro. Cancer Biother, 9(4): 351-358, 1994.
11. Kobayashi H., K. Matsunaga and M. Fujii. PSK as a chemopreventive agent. Cancer Epidemiol Biomarkers Prev, 2(3): 271-276, 1993.
12. Kobayashi H., K. Matsunaga and Y. Oguchi. Antimetastatic effects of PSK (krestin), a proteinbound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev, 4(3): 275-281, 1995.
13. Li J., M. Zhou and Y. Chen. Reversal of inhibition of reactive oxygen species on respiratory burst of macrophages by polysaccharide from Coriolus versicolor. Intern J Imimmopliarm, I5(3):429-433, 1993.
14. Liu S.X., M. Zhou and Y. Chen. Lipoperoxidative injury to macrophage by Ox-LDLmay play an important role in foam cell formation. Atherosclerosis, 121: 55-61, 1996.
15. Liu S.X., M. Zhou, Y. Chen and M.J. Sun. Injury to mitochondria of mouse peritoneal macrophages caused by oxidized low density lipoprotein and protective effect by a polysaccharide krestin from Coriolus versicolor. Med Sci Res, 24(10): 715-717, 1996.
16. Lou N., M. Zhou, Y. Chen and J. Li. Alteration of membrane fluidity, Superoxide dismutase activity and lipoperoxide content in monocytic cell line U937 cultured with tert-butyl hydroperoxide in vitro. Med Sci Res, 24(4): 225-227, 1996.
17. Lou N., M. Zhou and Y. Chen. Inhibitory effect of polysaccharide krestin on foam cell formation and necrosis of murine peritoneal macrophage caused by oxidized low density lipoprotein. Med Sci Res, 24(1): 49-51,1996.
18. Matsunaga K., M. Aota, Y. Nyunoya, M. Hakozaki, Y. Ishikuwa, M. Ohhara, N. Sugita and H. Endo. Antitumor effect of biological response modifier PSK on C57BL/6 mice with syngeneic melanoma B16 and its mode of action. Oncology, 51(4): 303-308, 1994.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65:55-63, 1983.
20. Nakazato H., A. Koike, S. Saji, N. Ogama and J. Sakamoto. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet, 343: 1122-1126, 1994.
21. Noguchi K., H. Tanimura, H. Yamaue, T. Tsunoda, M. hvahashi, M. Tani, S. Mizobata, T. Hotta, K. Arii and M. Tamai. Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vivo. Anticancer Res, 15(2): 255-258, 1995.
22. Palomba L., P. Sestili, F. Cattabeni, A. Azzi and O. Cantoni. Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cells. FEBS Lett, 390( 1 ): 91-94, 1996
23. Parthasarathy S., D. Steinberg and J.L. Witztum. The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Aiuni Rev Med, 43: 219-225, 1992.
24. Quillet-Mary A., V. Mansat, E. Duchayne, M.G. Come, M Allouche, J.D. Bailly, C. Bordier and G. Laurent. Daunorubicin induced internucleosomal DNA fragmentation in acute myeloid cell lines. Leukemia, 10(3): 417-425, 1996.
25. Reid V.C., M.J. Mitchinson and J.N. Skepper. Cytotoxicity of oxidized low density lipoprotein to mouse peritoneal macrophages: ultrastructural study. J Patlwl, 171(1): 321-328,1993.
26. Reid V.C., S.J. Hardwick and M.J. Mitchinson. Fragmentation of DNA in P388D1 macrophages exposed to oxidized low density lipoprotein. FEBS Lett 332(3): 218-220, 1993.
27. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362: 801-809, 1993.
28. Sakagami H., K. Sugaya, A. Utsami, S. Fujinaga, T. Sato and M. Takeda. Stimulation by PSK of interleukin-l production by human peripheral blood mononuclear cells. Anticancer Res, 13(3): 671-675,1993.
29. Steinberg D., S. Parthasarathy, T.E. Carew , J.C. Khoo and J.L. VVitztum. Modification of low density lipoprotein that increases its atherogenicity. N Engl J Med, 320: 915924,1989.
30. Steinbrecher U.P., H. Zhang and M. Lougheed. Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol Med, 9: 155-168, 1990.
31. Steinberg D. and J.L. Witztum. Lipoprotein and atherogenesis. JAMA, 264:3047-3052, 1990.
32. Sugimachi K., Y. Maehara, T. Kusumaoto, D. Korenaga, S. Kohnoe, H. Baba and H. Anai. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastro intestinal cancer. Anticancer Res. 15(5B): 2175-2179, 1995.
33. Takenoshita S., T. Hashizume, T. Asao, J. Nakanura, Y. Yajima, K. Shinozaki, Y. Shitara, H. Koilabashi, R. Katou and Y. Nagamachi. Inhibitory effects of combined administration of 5-Fu and Krestin on liver cancer KDH-8 in WKA/H rats. J Invest Sitrg, 8(1): 1-5, 1995.
34. UenoY., S. Kohgo Sakamaki,Y. Itoh, M.Takahashi,Y. Hirayama, Y. Niitsu. Immunochemotherapy in B-16 melanoma cell transplanted mice with combinations of interleukin-2, cyclophosphamide, and PSK. Oncology, 51(3): 296-302, 1994.
35. Witztum J.L. and D. Steinberg. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 88:1785-1792, 1991.
36. Xi L.Z. and X.G. Gu. Extraction Agentia, In: Xi LZ (ed.) Pharmaceutics. Beijing: Chinese People Hygiene Press. 1993, pp. 20-21.
37. Yang X., B. Cai and R.S. Sciacca. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low density lipoproteins. Circulation Res, 74(2): 318-312, 1994.
38. Yunoki S., N. Tanak, A. Hizuta and K. Orita. Enhancement of antitumor cytotoxicity of hepatic lymphocytes by oral administration of PSK. lut J linmunophannac, 16(2): 123-130,1994.
39. Zhou M., Y. Chen, N. Lou, S.X. Liu, Z.J. Pang and J. Wan. The polysaccharide krestin prevents lipoperoxidative injury to experimentally atherosclerotic rabbits. Med Sci Res, 25: 137-140,1997.